Related Experiment Video
Updated: May 8, 2026

Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
PDX-1 related diabetes: a case series of two families highlighting challenges in MODY diagnosis
Beatriz Tavares da Silva1, Ana Torrão Pinheiro2, Miguel Saraiva2
1Division of Endocrinology, Local Health Unit of Santo António, Centro Hospitalar Universitário de Santo António, Largo Prof. Abel Salazar, 4099-001, Porto, Portugal. beatriztavaresdasilva.md@gmail.com.
Abstract:
PDX1-MODY is a rare, dominantly inherited form of monogenic diabetes resulting from pathogenic variants in the PDX1 (IPF1) gene. It typically presents with early-onset, non-ketotic hyperglycemia and variable insulin dependence. This report describes two unrelated families carrying confirmed PDX1 variants (c.313G > T [p.Glu105*] and c.492G > T [p.Glu164Asp]) that illustrate the clinical and genetic heterogeneity of PDX1-MODY. Comprehensive next-generation sequencing (NGS) including a 36-gene panel for monogenic diabetes confirmed the variants, which were classified according to ACMG/AMP 2015 guidelines as "pathogenic" (p.Glu105)* and "likely pathogenic" (p.Glu164Asp). Clinically, both pedigrees exhibited preserved C-peptide secretion over decades, absence of autoimmune markers, and progressive β-cell dysfunction, confirming the variable but characteristic phenotype of PDX1-MODY. These cases expand the mutational and phenotypic spectrum of PDX1-MODY and highlight the importance of considering monogenic diabetes in early-onset, antibody-negative cases.
Insights
PDX1-MODY, a rare genetic diabetes, shows significant clinical and genetic diversity. Understanding these PDX1 gene variants is crucial for diagnosing early-onset diabetes.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- PDX1-MODY is a rare, dominantly inherited monogenic diabetes caused by PDX1 (IPF1) gene variants.
- It characteristically presents with early-onset, non-ketotic hyperglycemia and variable insulin needs.
Purpose of the Study:
- To investigate the clinical and genetic heterogeneity of PDX1-MODY.
- To expand the understanding of the PDX1-MODY mutational and phenotypic spectrum.
Main Methods:
- Next-generation sequencing (NGS) using a 36-gene panel for monogenic diabetes.
- Variant classification according to ACMG/AMP 2015 guidelines.
Main Results:
- Two unrelated families with confirmed PDX1 variants (p.Glu105* and p.Glu164Asp) were identified.
- Both pedigrees demonstrated preserved C-peptide secretion, absence of autoimmune markers, and progressive beta-cell dysfunction.
- Variants were classified as "pathogenic" and "likely pathogenic".
Conclusions:
- These cases highlight the clinical and genetic heterogeneity of PDX1-MODY.
- The findings underscore the importance of considering monogenic diabetes in antibody-negative, early-onset hyperglycemia cases.
Related Concept Videos
Inborn Errors of Metabolism
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

